# FDA Inspection 1313638 - Aykut Bayrak, MD A Professional Corporation - April 15, 2026

Source: https://www.keypedia.com/records/fda_inspections/aykut-bayrak-md-a-professional-corporation/b1cc6fd0-2e7b-431e-ab8a-a97fb9d2eee8
Source feed: FDA_Inspections

> FDA Inspection 1313638 for Aykut Bayrak, MD A Professional Corporation on April 15, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1313638
- Company Name: Aykut Bayrak, MD A Professional Corporation
- Inspection Date: 2026-04-15
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1200400 - 2023-03-01](https://www.keypedia.com/records/fda_inspections/aykut-bayrak-md-a-professional-corporation/ef31a165-4a26-450c-ad82-d273fb4c35b0)
- [FDA Inspection 1200400 - 2023-03-01](https://www.keypedia.com/records/fda_inspections/aykut-bayrak-md-a-professional-corporation/b0d74b13-691e-4734-a173-2c6309d1b392)
- [FDA Inspection 1200400 - 2023-03-01](https://www.keypedia.com/records/fda_inspections/aykut-bayrak-md-a-professional-corporation/6a472cd5-888a-45e5-8b4a-187ea098ae27)
- [FDA Inspection 1027851 - 2017-09-13](https://www.keypedia.com/records/fda_inspections/aykut-bayrak-md-a-professional-corporation/31810408-3f75-41db-beef-3709622f12d5)
- [FDA Inspection 1027851 - 2017-09-13](https://www.keypedia.com/records/fda_inspections/aykut-bayrak-md-a-professional-corporation/1e164883-c370-4b6d-9edf-246fdec8c7b7)

Company: https://www.keypedia.com/companies/aykut-bayrak-md-a-professional-corporation/d7308db6-dca3-4ba8-842b-143595bffc5e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d